There is an increasing trend of offering neoadjuvant systemic therapy in patients with LABC based on the 30%-39% pathological complete response (pCR) in patients with aggressive histology [ 16 ].
← all excerpts
Early Postoperative Outcomes of Breast Cancer Surgery in a Developing Country.
1
—
—